Trials / Active Not Recruiting
Active Not RecruitingNCT05186025
Tyrosine Allergoid Paediatric and Adult Study
A Long-term, Prospective, Open, Multi-centre, Non-interventional Study to Evaluate the Effectiveness After Treatment With TA Bäume Top (Trees) and TA Gräser Top (Grass) Following a Perennial Posology in Children and Adults, as Well as Proofing the Non-inferiority of Children Compared to Adults
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (actual)
- Sponsor
- Allergy Therapeutics · Industry
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this 5-year study is to demonstrate non-inferiority of children compared to adults by exploring long-term effectiveness after treatment with TA Bäume (trees) and TA Gräser (grass) following a perennial posology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MATA trees or MATA grass | Glutaraldehyde-modified and MCT® (MicroCrystalline Tyrosine)-adsorbed allergoids |
Timeline
- Start date
- 2020-11-06
- Primary completion
- 2026-06-01
- Completion
- 2026-10-01
- First posted
- 2022-01-11
- Last updated
- 2026-01-30
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05186025. Inclusion in this directory is not an endorsement.